Just when it appeared that the tariff uncertainty had eased, US President Donald Trump on Tuesday announced that all generic drugs imported into the country will face a 100% tariff from August 1, 2028, followed by a steep 200% tariff from August 1, 2029.
The announcement is significant as Trump's earlier pharmaceutical tariff measures were focused on branded and patented drugs, with that policy remaining unchanged. Generic medicines were not covered by the earlier measures, despite accounting for nearly 90% of prescriptions in the US.
